Radiotherapy - Anastrazole Concomitant : Evaluation of the Side Effects
NCT ID: NCT01183832
Last Updated: 2019-05-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
490 participants
OBSERVATIONAL
2005-08-31
2016-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Safety and Rheumatologic Tolerability of Letrozole in Postmenopausal Patients With Hormone Receptor Positive Breast Cancer
NCT00329940
Anastrozole in Preventing Breast Cancer in Postmenopausal Women at Increased Risk of Breast Cancer
NCT00078832
Ax-003/Arimidex (Anastrozole) in the Adjuvant Therapy of Early Breast Cancer
NCT00638391
Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy
NCT00053898
Letrozole, Anastrozole, Exemestane, or Tamoxifen Citrate in Treating Postmenopausal Women With Breast Cancer
NCT00893061
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Concomitant
In this group, anastrazole is concomitant to the radiotherapy
No interventions assigned to this group
Sequential
In this group, anastrazole is sequential to the radiotherapy (start after the end of radiotherapy)
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* No metastatic breast cancer, stade I-II, estrogen receptor positive or progesterone receptor positive, treated by conservative surgery or total mastectomy and requiring additive treatment by radiotherapy and hormonotherapy
* The patients including in another clinical trial can be include in this observatory
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Oscar Lambret
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yazid BELKACEMI, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Centre Oscar Lambret
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre Henri Becquerel
Amiens, , France
Clinique La Casamance
Aubagne, , France
Hôpital Duchêne
Boulogne-sur-Mer, , France
Centre François Baclesse
Caen, , France
Charleville, , France
Henri Mondor
Créteil, , France
Centre Oscar Lambret
Lille, , France
Clinique Clairval
Marseille, , France
Institut Paoli Calmettes
Marseille, , France
La Timone
Marseille, , France
Centre Val d'Aurelle
Montpellier, , France
Centre Catherine de Sienne
Nantes, , France
Centre Hospitalier St Grégoire
Nantes, , France
Nouvelles cliniques nantaises
Nantes, , France
Centre Antoine Lacassagne
Nice, , France
Centre Antoine LACCASSAGNE
Nice, , France
Clinique de la Roseraie
Paris, , France
Hôpital Européen Georges Pompidou HEGP
Paris, , France
Hôpital Pitié Salpêtrière
Paris, , France
Hôpital Saint Louis
Paris, , France
Centre Hospitalier LYON Sud
Pierre-Bénite, , France
Polyclinique de Courlancy
Reims, , France
Centre: Clinique Armoricaine de Radiologie
Saint-Brieuc, , France
Centre René Huguenin
Saint-Cloud, , France
Centre Paul Strauss
Strasbourg, , France
Centre de radiothérapie Saint-Louis
Toulon, , France
Centre Claudius REGAUD
Toulouse, , France
Institut Gustave Roussy
Villejuif, , France
Centre CHPG
Monaco, , Monaco
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ORACLES
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.